BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 39 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,773,700 | +25.1% | 10,000,000 | 0.0% | 0.05% | +30.8% |
| Q2 2023 | $7,814,800 | +5.0% | 10,000,000 | 0.0% | 0.04% | +8.3% |
| Q1 2023 | $7,443,800 | +62.1% | 10,000,000 | 0.0% | 0.04% | +63.6% |
| Q4 2022 | $4,590,800 | -22.6% | 10,000,000 | 0.0% | 0.02% | -18.5% |
| Q3 2022 | $5,931,000 | +8.3% | 10,000,000 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $5,477,000 | -7.7% | 10,000,000 | 0.0% | 0.02% | +9.1% |
| Q1 2022 | $5,936,000 | -19.5% | 10,000,000 | 0.0% | 0.02% | -21.4% |
| Q4 2021 | $7,372,000 | -66.7% | 10,000,000 | -37.5% | 0.03% | -71.1% |
| Q3 2021 | $22,119,000 | +124.5% | 16,000,000 | +166.7% | 0.10% | +115.6% |
| Q2 2021 | $9,853,000 | -0.8% | 6,000,000 | 0.0% | 0.04% | -16.7% |
| Q1 2021 | $9,930,000 | – | 6,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |